Legacy effects from DCCT and UKPDS: what they mean and implications for future diabetes trials.
Current Atherosclerosis Reports (2010)
- PubMed: 20652839
Available from www.ncbi.nlm.nih.gov
or
Abstract
The United Kingdom Prospective Diabetes Study (UKPDS) and the Diabetes Chronic Complications Trial (DCCT) are two landmark trials that convincingly demonstrated that tight glycemic control has beneficial effects on microvascular end points. These studies also revealed a "legacy effect," which is a sustained benefit with respect to cardiovascular disease outcomes seen long after the conclusion of the trial. We discuss possible molecular mechanisms that could play a role in causing the legacy effect.
Author-supplied keywords
Sign up today - FREE
Mendeley saves you time finding and organizing research. Learn more
- All your research in one place
- Add and import papers easily
- Access it anywhere, anytime
Start using Mendeley in seconds!
Readership Statistics
1 Reader on Mendeley
by Discipline
100% Medicine
by Academic Status
100% Post Doc
by Country
100% Denmark